OROS-methylphenidate or placebo for detained people with ADHD
About this title
Read the official source — NCT05842330Understand this study
Who could participate?
This study is for people with ADHD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
What will I do during this study?
During detention, participants are randomly assigned to three months of methylphenidate or placebo (an inactive comparison treatment). The dose is adjusted according to response and side effects; treatment is checked weekly during the first month, then monthly. Everyone also receives a cognitive behavioural education program in detention and therapy after release. Side effects are monitored daily in detention and every two weeks after release, with follow-up on behaviour for one year.
- Listed locations
- GenevaSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 150
- Sponsor
- Stéphanie Baggio
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Switzerland
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05842330
- Official title
Show the full official title
Benefits of In-prison OROS-methylphenidate vs. Placebo Treatment in Detained People With Attention-deficit/Hyperactivity Disorder: A Randomized Controlled Trial
Recruitment & locations
Geneva
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Stéphanie Baggio.
Does this study involve medication?
Yes. The study involves medication, including Concerta and Placebo.
Who can participate?
This study is for people with ADHD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
